Concepedia

Burcu Temizoz

BT

Statistics

Publications

15

Citations

586

H-Index

13

Active since

2014

Affiliations

The University of Osaka(Current)

National Institute of Biomedical Innovation, Health and Nutrition

The University of Tokyo

Yokohama City University

Hyogo Medical University

Burcu Temizoz is an author at The University of Osaka specializing in immunology, life sciences, and innate immunity.

ORCID

Publications per year

2014–2025

15

Publications

15

TLR9 and STING agonists synergistically induce innate and adaptive type‐II IFN

Burcu Temizoz, Etsushi Kuroda, Keiichi Ohata et al. · European Journal of Immunology · 2014 · 152 citations · Full text

, , +17

Inhaled Fine Particles Induce Alveolar Macrophage Death and Interleukin-1α Release to Promote Inducible Bronchus-Associated Lymphoid Tissue Formation

Etsushi Kuroda, Koji Ozasa, Burcu Temizoz et al. · Immunity · 2016 · 139 citations · Full text

, , +11

Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor

Koji Ozasa, Burcu Temizoz, Takato Kusakabe et al. · Frontiers in Immunology · 2019 · 57 citations · Full text

, , +17

Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation

Burcu Temizoz, Kou Hioki, Shingo Kobari et al. · International Immunology · 2022 · 29 citations

, , +17

CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study

Tomoyuki Otsuka, Sumiyuki Nishida, Takayuki Shibahara et al. · BMC Cancer · 2022 · 28 citations · Full text

, , +15

1–5 of 15